Enleofen co-founders identify IL-11 as pulmonary fibrosis target

By Claire Quang | Oct 28, 2019 | 11:42 PM GMT

DISEASE CATEGORY: Pulmonary

INDICATION: Pulmonary fibrosis

A National Heart Centre Singapore team led by Enleofen Bio Pte. Ltd. co-founders

Read the full 179 word article

How to gain access

Continue reading with a
two-week free trial.